A Prospective Study on High Sensitivity C - Reactive Protein in Acute Ischemic Stroke Patients in a Medical College Hospital

One of the biomarkers for the ischemic stroke is CRP, the first acute-phase protein exquisitely sensitive systemic marker of inflammation and tissue damage. The current research focused the evaluation and the predictive value of hs-CRP (high sensitivity C - Reactive Protein) in relation to the ultimate functional outcome in first ever ischemic stroke after 4 weeks and to correlate the hs-CRP levels with various risk factors. A total number of 50 subjects were included in the study. The hs-CRP levels were compared with age, gender, time of sample collection, time interval of sample collection, total serum cholesterol, smokering and alcohol consumption. Patients with elevated hs-CRP had a poorer outcome when compared to patients with lower levels of CRP, four weeks after the onset of ischemic stroke. hs-CRP levels had no significant correlation with age or gender. hs-CRP did not show a statistically significant correlation with smoking or cholesterol intake.